In India, the burden of cardiovascular disease (CVD) surpasses global averages significantly. With an age-standardized death rate of 282 deaths/100,000 for CVD, India exceeds the global rate of 233 deaths/100,000. Moreover, CVD-related age-standardized DALY rates in India are 1.3 times the global average, contributing significantly to global DALYs for ischemic heart disease (IHD), stroke, and rheumatic heart disease. Indians experience CVD a decade earlier than those of European ancestry, with two-thirds of cardiovascular deaths occurring prematurely. Factors such as education, socio-economic status, and physiological differences, including higher insulin resistance and prevalence of diabetes, contribute to this heightened risk. Despite these challenges, treatment and control levels for hypertension and diabetes remain low in India, underscoring the urgent need for comprehensive intervention strategies.
What is Clopibond Gold?
Clopibond Gold is a combination medication used to reduce the risk of cardiovascular events such as heart attack and stroke. It contains three active ingredients: Clopidogrel 75mg, rosuvastatin 10mg or 20mg, and aspirin. This combination helps prevent blood clots, lower cholesterol levels, and reduce inflammation, all of which are important factors in reducing the risk of heart disease.
How Does Clopibond Gold Work?
Each component of Clopibond Gold serves a specific purpose:
By combining these three medications, Clopibond Gold provides a triple-action approach to reducing the risk of cardiovascular events.
Benefits of Clopibond Gold
Talk to your doctor to learn more about CLOPIBOND GOLD
REUEL PHARMACEUTICALS
52/3216 - A Vembully Lane, Vyttila, Cochin, Ernakulam, Kerala 682019 | Kootezhath Bldg, Kuvempu Layout, Hebbal-Kempapura, Bangalore-560024
Copyright © 2024 REUEL PHARMACEUTICALS - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.